Advertisement
U.S. Markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
14.85+0.29 (+1.99%)
At close: 04:00PM EDT
15.05 +0.20 (+1.35%)
After hours: 04:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close14.56
Open14.50
Bid0.00 x 0
Ask0.00 x 0
Day's Range14.23 - 14.98
52 Week Range4.69 - 20.90
Volume139,356
Avg. Volume252,476
Market Cap661.862M
Beta (5Y Monthly)0.69
PE Ratio (TTM)N/A
EPS (TTM)-0.56
Earnings DateNov 11, 2024 - Nov 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.80
  • GuruFocus.com

    Y-mAbs Therapeutics Inc (YMAB) Q2 2024 Earnings Call Highlights: Revenue Growth Driven by ...

    Y-mAbs Therapeutics Inc (YMAB) reports a 10% increase in DANYELZA revenue, fueled by international sales, while facing competitive pressures in the US market.

  • GlobeNewswire

    Y-mAbs to Participate in Upcoming Investor Conferences in October

    NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced that its management team will participate in the following upcoming investor conferences: Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology SummitDate: Tuesday, Octob